DCVC Bio is a VC fund investing in early-stage computational biology startups. Advances in genetic sequencing, artificial intelligence and automation are converging to transform existing life sciences technologies and speed the development of new ones. We are looking for companies affecting deep technological change in synthetic biology, medicine, and agriculture. We are especially interested in teams shaping the biochemical building blocks the life sciences industry runs on.

Learn more about us at www.dcvc.com, read our blog at www.medium.com/@dcvc, and follow us on Twitter at @DCVCBio.